BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Petruccioli E, Chiacchio T, Navarra A, Vanini V, Cuzzi G, Cimaglia C, Codecasa LR, Pinnetti C, Riccardi N, Palmieri F, Antinori A, Goletti D. Effect of HIV-infection on QuantiFERON-plus accuracy in patients with active tuberculosis and latent infection. J Infect 2020;80:536-46. [PMID: 32097688 DOI: 10.1016/j.jinf.2020.02.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Riccardi N, Villa S, Canetti D, Giacomelli A, Taramasso L, Martini M, Di Biagio A, Bragazzi NL, Brigo F, Sotgiu G, Besozzi G, Codecasa L. Missed opportunities in tb clinical practice: How to bend the curve? A medical, social, economic and ethical point of view. Tuberculosis (Edinb) 2021;126:102041. [PMID: 33385833 DOI: 10.1016/j.tube.2020.102041] [Reference Citation Analysis]
2 Bayaa R, Ndiaye MDB, Chedid C, Kokhreidze E, Tukvadze N, Banu S, Uddin MKM, Biswas S, Nasrin R, Ranaivomanana P, Raherinandrasana AH, Rakotonirina J, Rasolofo V, Delogu G, De Maio F, Goletti D, Endtz H, Ader F, Hamze M, Ismail MB, Pouzol S, Rakotosamimanana N, Hoffmann J; HINTT working group within the GABRIEL network. Multi-country evaluation of RISK6, a 6-gene blood transcriptomic signature, for tuberculosis diagnosis and treatment monitoring. Sci Rep 2021;11:13646. [PMID: 34211042 DOI: 10.1038/s41598-021-93059-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 MacGregor-Fairlie M, Wilkinson S, Besra GS, Goldberg Oppenheimer P. Tuberculosis diagnostics: overcoming ancient challenges with modern solutions. Emerg Top Life Sci 2020;4:423-36. [PMID: 33258943 DOI: 10.1042/ETLS20200335] [Reference Citation Analysis]
4 Picchianti-Diamanti A, Aiello A, Laganà B, Agrati C, Castilletti C, Meschi S, Farroni C, Lapa D, Najafi Fard S, Cuzzi G, Cimini E, Grassi G, Vanini V, Di Rosa R, Salemi S, Nalli G, Salmi A, Repele F, Altera AMG, Maffongelli G, Palazzolo C, Vita S, Leone S, Puro V, Capobianchi MR, Ippolito G, Nicastri E, Goletti D. ImmunosuppressiveTherapies Differently Modulate Humoral- and T-Cell-Specific Responses to COVID-19 mRNA Vaccine in Rheumatoid Arthritis Patients. Front Immunol 2021;12:740249. [PMID: 34594343 DOI: 10.3389/fimmu.2021.740249] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
5 Lee JK, Lee HW, Heo EY, Yim JJ, Kim DK. Comparison of QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube tests for patients with active and latent tuberculosis: A prospective cohort study. J Infect Chemother 2021;27:1694-9. [PMID: 34412980 DOI: 10.1016/j.jiac.2021.08.003] [Reference Citation Analysis]
6 Ong CWM, Migliori GB, Raviglione M, MacGregor-Skinner G, Sotgiu G, Alffenaar JW, Tiberi S, Adlhoch C, Alonzi T, Archuleta S, Brusin S, Cambau E, Capobianchi MR, Castilletti C, Centis R, Cirillo DM, D'Ambrosio L, Delogu G, Esposito SMR, Figueroa J, Friedland JS, Ho BCH, Ippolito G, Jankovic M, Kim HY, Rosales Klintz S, Ködmön C, Lalle E, Leo YS, Leung CC, Märtson AG, Melazzini MG, Najafi Fard S, Penttinen P, Petrone L, Petruccioli E, Pontali E, Saderi L, Santin M, Spanevello A, van Crevel R, van der Werf MJ, Visca D, Viveiros M, Zellweger JP, Zumla A, Goletti D. Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC). Eur Respir J 2020;56:2001727. [PMID: 32586885 DOI: 10.1183/13993003.01727-2020] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 13.0] [Reference Citation Analysis]
7 Cai Q, Shen X, Li H, Yao C, Sun N, Wang J, Wu H, Yuan C, Xiang J, Xiang Y. Diagnostic performance of culture filtered protein 10-specific perforin in pediatric patients with active tuberculosis. J Clin Lab Anal 2020;34:e23477. [PMID: 32671908 DOI: 10.1002/jcla.23477] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Chen H, Nakagawa A, Takamori M, Abe S, Ueno D, Horita N, Kato S, Seki N. Diagnostic accuracy of the interferon-gamma release assay in acquired immunodeficiency syndrome patients with suspected tuberculosis infection: a meta-analysis. Infection. [DOI: 10.1007/s15010-022-01789-9] [Reference Citation Analysis]
9 Soler-Garcia A, Gamell A, Pérez-Porcuna T, Soriano-Arandes A, Santiago B, Tórtola T, Ruiz-Serrano MJ, Korta Murua JJ, Bustillo-Alonso M, Garrote-Llanos MI, Rodríguez-Molino P, Piqueras AI, Tagarro A, Monsonís M, Tebruegge M, Noguera-Julian A; QFT-Plus Study Group of the Spanish Pediatric TB Research Network. Performance of QuantiFERON-TB Gold Plus assays in children and adolescents at risk of tuberculosis: a cross-sectional multicentre study. Thorax 2021:thoraxjnl-2021-217592. [PMID: 34876500 DOI: 10.1136/thoraxjnl-2021-217592] [Reference Citation Analysis]
10 Teng VYM, Chua YT, Lai EEN, Mukherjee S, Michaels J, Wong CS, Shen L, Leo YS, Young B, Archuleta S, Ong CWM. Lack of latent tuberculosis (TB) screening and delay in anti-retroviral therapy initiation in HIV-TB co-infection: an 11-year study in an intermediate TB-burden country. Int J Infect Dis 2021;113:178-83. [PMID: 34563709 DOI: 10.1016/j.ijid.2021.09.048] [Reference Citation Analysis]
11 Tang J, Huang Y, Jiang S, Huang F, Ma T, Qi Y, Ma Y. QuantiFERON-TB Gold Plus combined with HBHA-Induced IFN-γ release assay improves the accuracy of identifying tuberculosis disease status. Tuberculosis (Edinb) 2020;124:101966. [PMID: 32866942 DOI: 10.1016/j.tube.2020.101966] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Birku M, Desalegn G, Kassa G, Tsegaye A, Abebe M. Effect of pregnancy and HIV infection on detection of latent TB infection by Tuberculin Skin Test and QuantiFERON-TB Gold In-Tube assay among women living in a high TB and HIV burden setting. Int J Infect Dis 2020;101:235-42. [PMID: 33039610 DOI: 10.1016/j.ijid.2020.09.1452] [Reference Citation Analysis]
13 Çavuşoğlu C, Yaşar-Duman M, Sezai Taşbakan M, Işıkgöz-Taşbakan M, Nurullah Orman M. Evaluation of the performance of QuantiFERON®-TB Gold plus test in active tuberculosis patients. J Clin Tuberc Other Mycobact Dis 2021;23:100223. [PMID: 33665376 DOI: 10.1016/j.jctube.2021.100223] [Reference Citation Analysis]
14 Imoto S, Suzukawa M, Takeda K, Asari I, Watanabe S, Tohma S, Nagase T, Ohta K, Teruya K, Nagai H. Evaluation of cytokine levels in response to mitogen among HIV-1-infected blood cells and their relationships to the number of T cells. Cytokine 2022;153:155840. [PMID: 35276635 DOI: 10.1016/j.cyto.2022.155840] [Reference Citation Analysis]
15 Oh CE, Ortiz-Brizuela E, Bastos ML, Menzies D. Comparing the Diagnostic Performance of QuantiFERON-TB Gold Plus to Other Tests of Latent Tuberculosis Infection: A Systematic Review and Meta-analysis. Clin Infect Dis 2021;73:e1116-25. [PMID: 33289038 DOI: 10.1093/cid/ciaa1822] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]